According to Future Market Insights’ recent report, the Spine Pain Market forecast to register a CAGR of 5% from 2023 to 2033, reaching a valuation of US$ 12.47 Billion. Anti-inflammatory medications’ minor side effects are encouraging an increase in their usage as pain relievers. The effectiveness of pharmaceuticals like diclofenac, ibuprofen, and naproxen as nonsteroidal anti-inflammatory treatments is aiding the sector’s growth.
Spine Pain, also known as back pain or spinal pain, refers to discomfort or distress experienced in the area of the spine, which extends from the base of the skull to the tailbone. It is a common condition that can affect people of all ages and is often caused by various factors such as muscle strain, poor posture, injury, or underlying medical conditions. Spine Pain can manifest as localized discomfort, aching sensations, stiffness, or radiating pain that travels to other parts of the body.
Unlock growth potential with industry expertise. Download your market sample report now: https://www.futuremarketinsights.com/reports/sample/rep-gb-16283
The impact of Spine Pain on an individual’s daily life can be significant, as it can limit mobility, interfere with work or daily activities, and affect overall quality of life. It is essential to seek medical attention if Spine Pain persists or worsens over time. Treatment options for Spine Pain may include conservative measures such as rest, physical therapy, pain medication, and lifestyle modifications. In more severe cases, surgical intervention may be necessary. Proper diagnosis, effective management, and preventive measures like maintaining a healthy weight, regular exercise, and practicing good posture can help alleviate Spine Pain and promote spinal health.
Market Drivers:
Anti-inflammatory medications’ modest side effects are encouraging a rise in their use as pain treatments. The effectiveness of medications like diclofenac, ibuprofen, and naproxen as nonsteroidal anti-inflammatory treatments is supporting the sector’s expansion.
In addition, lesser doses of these medications are commonly available without a doctor’s prescription. The spine pain business is predicted to rise as market participants work to develop novel NSAIDs that will relieve patients’ pain.
The vast majority of people in the area who suffer from chronic spine pain contribute to the market’s expansion. Because of rising healthcare costs for the general public and the availability of cutting-edge healthcare systems, the industry for spine pain treatment in North America is gaining momentum. Growing research efforts to identify the underlying causes of spine pain and develop effective treatment options are projected to fuel market growth in the future decades.
Market Restraints:
Certain factors, such as a lack of information about the severity of chronic spine pain and a population’s reluctance to identify and treat the medical issue, are expected to limit the market’s growth over the projected period.
Have a Question About Vital Trends, Drivers, and Challenges in this Industry? Ask an Analyst: https://www.futuremarketinsights.com/ask-question/rep-gb-16283
Market Competition
Key players in the Spine Pain market are Medtronic plc., DePuy Synthes, Inc, Stryker Corporation, NuVasive, Inc, Zimmer Biomet Holdings, Inc., Globus Medical, Inc., Alphatec Spine, Inc, Orthofix International N.V., Difusion Technologies, Inc., ZimVie Inc.
- In July 2020 – Zavation Medical announced the release of the versatile anterior lumbar plate and Lateral Lumbar Plate, which are intended to be used as supplemental fixation devices for the lumbar spine. These plates are new additions to the company’s inventory.
- In August 2020, WishBone Medical Inc. declared the acquisition of all assets from Back 2 Basics Direct (B2B) and Orbbo Surgical, two confidentially medical device manufacturers specialized in spinal fusion research, advancement, and surgical tools.
More Valuable Insights
Future Market Insights, in its new offering, presents an unbiased analysis of the global Spine Pain market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.
The study reveals essential insights on the basis Product (Fusion Devices, Non-Fusion Devices, Stimulation Devices), By Treatment (Open Surgery, Minimally Invasive Surgery, Others), By Procedure (Discectomy, Laminotomy, Foraminotomy, Corpectomy, Facetectom) & Region (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa).
Purchase Now to Access Segment-specific Information and Acquisitions: https://www.futuremarketinsights.com/checkout/16283
About Future Market Insights, Inc.
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs